Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 1040-1048

  Cho, Kazumitsu ^a   Matsuda, Yoko ^a   Ueda, Junji ^a   Uchida, Eiji ^a   Naito, Zenya ^a   Ishiwata, Toshiyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Keratinocyte growth factor; KGF receptor; Matrix metalloproteinase 9; Pancreatic cancer; Venous invasion

Indexed keywords

COLLAGEN TYPE 4; GELATINASE B; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; MESSENGER RNA; RECOMBINANT KERATINOCYTE GROWTH FACTOR;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER PROGNOSIS; CAPILLARY BASEMENT MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VEIN INVASION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; FIBROBLAST GROWTH FACTOR 7; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TRANSFECTION;

EID: 84858681121     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1280     Document Type: Article

References (49)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Bardeesy N and DePinho RA: Pancreatic cancer biology and genetics. Nat Rev Cancer 2: 897-909, 2002. (Pubitemid 37328891)
3. Korc M: Driver mutations: a roadmap for getting close and personal in pancreatic cancer. Cancer Biol Ther 10: 588-591, 2010.
4. Itakura J, Ishiwata T, Friess H, et al: Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 3: 1309-1316, 1997. (Pubitemid 27362391)
5. Yamanaka Y: The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer. Nihon Ika Daigaku Zasshi 59: 51-61, 1992.
6. Kornmann M, Ishiwata T, Beger HG and Korc M: Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 15: 1417-1424, 1997. (Pubitemid 27437831)
7. Friess H, Yamanaka Y, Buchler M, Kobrin MS, Tahara E and Korc M: Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 56: 668-674, 1994. (Pubitemid 24086769)
8. Yamanaka Y, Friess H, Buchler M, et al: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 53: 5289-5296, 1993. (Pubitemid 23333401)
9. Friess H, Yamanaka Y, Buchler M, et al: Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105: 1846-1856, 1993. (Pubitemid 24002804)
10. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchier M and Beger HG: Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 90: 1352-1360, 1992.
11. Ishiwata T, Friess H, Buchler MW, Lopez ME and Korc M: Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 153: 213-222, 1998. (Pubitemid 28317524)
12. Hruban RH, Maitra A and Goggins M: Update on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol 1: 306-316, 2008.
13. Garcea G, Neal CP, Pattenden CJ, Steward WP and Berry DP: Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 41: 2213-2236, 2005. (Pubitemid 41415597)
14. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S and Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802-806, 1989. (Pubitemid 19056244)
15. Finch PW, Rubin JS, Miki T, Ron D and Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245: 752-755, 1989. (Pubitemid 19214010)
16. Rubin JS, Bottaro DP, Chedid M, et al: Keratinocyte growth factor. Cell Biol Int 19: 399-411, 1995.
17. Nguyen HQ, Danilenko DM, Bucay N, et al: Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. Oncogene 12: 2109-2119, 1996. (Pubitemid 26168420)
18. Playford RJ, Marchbank T, Mandir N, et al: Effects of keratinocyte growth factor (KGF) on gut growth and repair. J Pathol 184: 316-322, 1998. (Pubitemid 28112789)
19. Watanabe M, Ishiwata T, Nishigai K, Moriyama Y and Asano G: Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer. Pathol Int 50: 363-372, 2000. (Pubitemid 30451479)
20. Eswarakumar VP, Lax I and Schlessinger J: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149, 2005. (Pubitemid 40616112)
21. Mohammadi M, Olsen SK and Ibrahimi OA: Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 16: 107-137, 2005. (Pubitemid 40616111)
22. Miki T, Bottaro DP, Fleming TP, et al: Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89: 246-250, 1992.
23. Kurban G, Ishiwata T, Kudo M, Yokoyama M, Sugisaki Y and Naito Z: Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer. Oncol Rep 11: 987-991, 2004.
24. Yoshino M, Ishiwata T, Watanabe M, et al: Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells. Int J Oncol 31: 721-728, 2007.
25. Yan G, Fukabori Y, McBride G, Nikolaropolous S and McKeehan WL: Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13: 4513-4522, 1993. (Pubitemid 23220358)
26. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006. (Pubitemid 43723979)
27. Jones L, Ghaneh P, Humphreys M and Neoptolemos JP: The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann N Y Acad Sci 880: 288-307, 1999. (Pubitemid 29349137)
28. John A and Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23, 2001. (Pubitemid 32591662)
29. Bloomston M, Zervos EE and Rosemurgy AS II: Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol 9: 668-674, 2002. (Pubitemid 34857984)
30. Harvey SR, Hurd TC, Markus G, et al: Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res 9: 4935-4943, 2003. (Pubitemid 37323300)
31. Kuniyasu H, Ellis LM, Evans DB, et al: Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin Cancer Res 5: 25-33, 1999. (Pubitemid 29045174)
32. Cho K, Ishiwata T, Uchida E, et al: Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol 170: 1964-1974, 2007. (Pubitemid 47339270)
33. Fingleton B: Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 11: 479-491, 2006.
34. Kerkela E and Saarialho-Kere U: Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12: 109-125, 2003. (Pubitemid 36934696)
35. Mook OR, Frederiks WM and Van Noorden CJ: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004. (Pubitemid 39592897)
36. Folgueras AR, Pendas AM, Sanchez LM and Lopez-Otin C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424, 2004. (Pubitemid 39360392)
37. Hofmann UB, Houben R, Brocker EB and Becker JC: Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87: 307-314, 2005. (Pubitemid 40387609)
38. Koshiba T, Hosotani R, Wada M, et al: Detection of matrix metalloproteinase activity in human pancreatic cancer. Surg Today 27: 302-304, 1997. (Pubitemid 27164188)
39. Maatta M, Soini Y, Liakka A and Autio-Harmainen H: Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin Cancer Res 6: 2726-2734, 2000. (Pubitemid 30482111)
40. Kimura Y, Kobari M, Yusa T, et al: Establishment of an experi-mental liver metastasis model by intraportal injection of a newly derived human pancreatic cancer cell line (KLM-1). Int J Pancreatol 20: 43-50, 1996. (Pubitemid 26292147)
41. Parsons SL, Watson SA, Brown PD, Collins HM and Steele RJ: Matrix metalloproteinases. Br J Surg 84: 160-166, 1997. (Pubitemid 27073454)
42. Kanno N, Nonomura N, Miki T, et al: Effects of epidermal growth factor on the invasion activity of the bladder cancer cell line. J Urol 159: 586-590, 1998. (Pubitemid 28049286)
43. Miyake H, Yoshimura K, Hara I, Eto H, Arakawa S and Kamidono S: Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. J Urol 157: 2351-2355, 1997. (Pubitemid 27208720)
44. Lamoreaux WJ, Fitzgerald ME, Reiner A, Hasty KA and Charles ST: Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 55: 29-42, 1998. (Pubitemid 28368411)
45. Narita K, Fujii T, Ishiwata T, et al: Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells. Int J Oncol 34: 355-360, 2009.
46. Yamamoto H, Itoh F, Iku S, et al: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol 19: 1118-1127, 2001. (Pubitemid 32176289)
47. Koshiba T, Hosotani R, Wada M, et al: Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 82: 642-650, 1998. (Pubitemid 28090274)
48. Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW and Williams ED: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66: 11271-11278, 2006. (Pubitemid 46009956)
49. Kwabi-Addo B, Ropiquet F, Giri D and Ittmann M: Alternative splicing of fibroblast growth factor receptors in human prostate cancer. Prostate 46: 163-172, 2001.